USPTO serial 79223777
Serial No. 79223777
Reviewed by CopyMark Law Group
Reg. 5582931Status 709
- Filing date
- Status date
- Registration date
- Oct 16, 2018
- Examiner
- GOODSAID, IRA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79223777?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of brain, mental and nervous system disorders, vertigo, cardiovascular issues, strokes, neurodegenerative diseases, infections, atherosclerosis, attention deficit disorder, hyperpiesis, neuroticism, psychosomatic diseases, stress disorders, asthenic syndrome, neurotoxicosis and obesity; veterinary preparations for the treatment of neuroticism and stress disorders; pharmaceuticals and veterinary preparations for use in the treatment of diabetes and complications from diabetes, insulin resistance, inflammation and inflammatory diseases, respiratory and infectious diseases, nasal congestion, coughs, fever, colds, flu, immunological problems, fungal infections, viral infections, herpes, chicken pox, mononucleosis, hemorrhagic fever, encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis and pneumonia; antibacterial preparations; antihistamines; pharmaceutical preparations for the treatment of AIDS and HIV infection; psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, and menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome and gastrointestinal disorders; anticonvulsants; antianxiety preparations; cough treatment preparations; pharmaceutical preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy and ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; antioxidants; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose and glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention and treatment of mental and neurological disorders and conditions; psychoactive pharmaceutical preparations; anxiolytics, nootropics, psycholeptics, sedatives, antidepressants and neuroleptics; pharmaceutical preparations which stimulate the parasympathetic nervous system, enhance memory function, and prevent and alleviate stress and attention deficit disorder; lactose for pharmaceutical purposes; capsules sold empty for pharmaceuticals; vitamin preparations; medical preparations for slimming purposes; nerve calming preparations for medical purposes; appetite suppressant pills | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 6, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 6, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 2, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 2, 2025 | C71T | CANCELLED SECTION 71 | — |
| Oct 16, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 15, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 29, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 29, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 16, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 16, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2018 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jun 1, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 4, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 1, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 1, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 11, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 27, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 26, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 27, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 18, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2018 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jan 6, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 2, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 2, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 2, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 28, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |